Wanbury Ltd's Q4FY25 Quarter Results
- 16 May 2025
Result Summary
- Wanbury Ltd reported a 4.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 7.2%.
- Its expenses for the quarter were down by 0.8% QoQ and up 2.0% YoY.
- The net profit increased 2656.6% QoQ and increased 3197.1% YoY.
- The earnings per share (EPS) of Wanbury Ltd stood at 10.1 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 140.33 | 134.29 | 130.91 | 4.5% | 7.2% |
Total Expenses | 131.98 | 133.00 | 129.39 | -0.8% | 2.0% |
Profit Before Tax | 33.91 | 1.29 | 0.92 | 2528.7% | 3585.9% |
Tax | 0.27 | 0.07 | -0.10 | 285.7% | -370.0% |
Profit After Tax | 33.63 | 1.22 | 1.02 | 2656.6% | 3197.1% |
Earnings Per Share | 10.10 | 0.30 | 0.50 | 3266.7% | 1920.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Wanbury Ltd is a pharmaceutical company involved in the production and distribution of active pharmaceutical ingredients (APIs) and formulations. The company has established itself in the pharmaceutical industry with a focus on both domestic and international markets. Wanbury Ltd's product portfolio includes a range of therapeutic categories, serving diverse healthcare needs. The company has been actively engaged in expanding its manufacturing capacities and enhancing its product offerings to meet the growing demands of the healthcare sector. Any recent major developments specific to Wanbury Ltd are not available in the provided data.
Revenue
In the fourth quarter of fiscal year 2025 (Q4FY25), Wanbury Ltd reported a total income of ₹140.33 crores. This represents a quarter-over-quarter (QoQ) increase of 4.5% from the third quarter of fiscal year 2025 (Q3FY25), where the total income was ₹134.29 crores. Additionally, there is a year-over-year (YoY) growth of 7.2% compared to the fourth quarter of fiscal year 2024 (Q4FY24), which recorded a total income of ₹130.91 crores. The consistent growth in total income over the quarters indicates a steady upward trend in revenue generation for the company.
Profitability
The company reported a significant increase in profitability for Q4FY25, with a profit before tax of ₹33.91 crores. This marks a dramatic improvement from Q3FY25, where the profit before tax was ₹1.29 crores, showing a QoQ growth of 2528.7%. The YoY growth in profit before tax is even more pronounced at 3585.9% compared to ₹0.92 crores in Q4FY24. After accounting for taxes, the profit after tax for Q4FY25 stood at ₹33.63 crores, reflecting a substantial increase from ₹1.22 crores in Q3FY25 and ₹1.02 crores in Q4FY24. The earnings per share (EPS) for Q4FY25 was ₹10.10, which is a significant increase from ₹0.30 in Q3FY25 and ₹0.50 in Q4FY24, indicating a remarkable improvement in the company's profitability metrics.
Operating Metrics
Wanbury Ltd's total expenses for Q4FY25 amounted to ₹131.98 crores, showing a slight decrease of 0.8% QoQ from ₹133.00 crores in Q3FY25. Despite the decrease in expenses, there is a 2.0% increase YoY compared to ₹129.39 crores in Q4FY24. The company's tax expenses also rose significantly, with Q4FY25 recording ₹0.27 crores, up from ₹0.07 crores in Q3FY25 and contrasting with a tax reversal of ₹-0.10 crores in Q4FY24. These metrics highlight the company's ability to manage its expenses effectively while improving its tax strategy. The operating performance reflects a positive trajectory in financial management and cost efficiencies over the reported periods.